The inhibition of PI3K/Akt pathway has shown promise in sensitizing pancreatic cancer cells towards apoptosis induced by gemcitabine as well as other chemotherapeutics both in vitro and in vivo[61]. This evidence concerns the gene AKT1 and pancreatic neoplasm.